Advertisement

Topics

OvaScience Reports Fourth Quarter and Year-End 2016 Financial Results

16:06 EST 2 Mar 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
OvaTure Program On Track to Successfully Fertilize a Bovine EggPC Cell-Derived Egg 50 Patients Enrolled in OvaPrime Clinical Trial Cash Position Expected to Support Operations into Q12019 Confer...

Other Sources for this Article

Media and Investor Contact:
OvaScience, Inc.
Jennifer Viera, 617-420-8748
jviera@ovascience.com

NEXT ARTICLE

More From BioPortfolio on "OvaScience Reports Fourth Quarter and Year-End 2016 Financial Results"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...